Cite
HARVARD Citation
El Haddad, L. et al. (2019). The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients. Journal of infectious diseases. pp. 898-907. [Online].